Anastrozole vs Exemestane
A clean factual split between two ancillaries that get compared constantly. The mechanism difference is real and easy to state without giving any dosing guidance.
Side by side
| Anastrozole | Exemestane | |
|---|---|---|
| Class | Ancillaries | Ancillaries |
| Form | Oral | Oral |
| Half-life | ≈ 2.1 days (50 h) | ≈ 24 hours |
| Storage | Room temperature | Room temperature |
| Dose units | mg | mg |
| FDA status | Approved | Approved |
Facts from the Stack compound library. See the full pages: Anastrozole · Exemestane.
How they differ
Class
Anastrozole is non-steroidal and binds the aromatase enzyme reversibly. Exemestane is steroidal and binds irreversibly — the enzyme has to be remade. Same target, different chemistry.
Practical implication
The reversible-vs-irreversible difference is the main thing people mean when they compare these. How that maps to any individual's use is strictly a clinician's call.
Tracking
Both are orals taken on a schedule alongside other compounds; both fit cleanly into a protocol group you can pause as a unit.
Status
See each entry for FDA status — stated plainly on every library page.
Tracking either one
Whichever you log, the workflow is the same in Stack: add it once, set the schedule, and let the app handle reminders, supply projection and an "in your system" curve from the half-life. Run both? Group them into one protocol you can pause together.
Track your stack in Stack
Free to track — doses, schedules, supply and reminders in one quiet app. Your health data stays encrypted on your device.
Get the appLast reviewed 2026-06-11